Twitter censors the entire website of a prestigious medical journal

Twitter says scientific studies cause real world harm

The entire website of the European Journal of Medical and Health Sciences [EJMED], an international peer-reviewed medical journal, is being suppressed and libeled by Twitter.

Any link to the journal’s website results in a message from Twitter denouncing the journal as containing dangerous information that could cause “real-world harm.” If you proceed to the website despite Twitter’s warning, you have to click a special link that tracks you. This means Twitter is potentially adding a black mark to your account.

EJMED is part of Europa Publishing, which has a stated goal of making scientific studies more accessible to the public. Europa Publishing never charges fees to read medical studies online.

It is being suggested that Twitter is suppressing the site because of an article from Bangladeshi researchers published last December. This study does appear to be among the most popular on the website. The study was on the effectiveness of Ivermectin as a Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka. Ivermectin is a common anti-parasite drug.

The researchers spent four months tracking 118 Bangladeshi health care workers who were treating Covid-19 patients. Sixty of them were part of a control group, and 58 of them were taking Ivermectin. During that time, most of the control group tested positive for Covid-19, but very few people in the test group ever did.

This is the conclusion drawn by the researchers:

Ivermectin, an FDA-approved, safe, cheap, and widely available drug should be subjected to large-scale trials all over the world to ascertain its effectiveness as pre-exposure prophylaxis for COVID-19.

The conclusion obviously does not constitute anything radical or dangerous.

Shortly after the study was published, the website Rebel EM reviewed nine different studies concerning Ivermectin & Covid-19. Rebel EM was highly critical of the studies and strongly disputed the quality of the findings. Some of the studies, they denounced outright. However, they regarded the Bangladeshi study published in EJMED as the most promising of the nine:

Of all the studies reviewed in this post, this is the most promising. However it’s a single center study, observational and there are a number of factors that are unknown. Given the high conversion rate in the control group, it would be important to know what level of PPE was being used and if it was different between groups. Additionally, there was no patient oriented outcomes relegating the results of this study to promising and hypothesis generating requiring larger RCTs to confirm the results.

EJMED has published a multitude of papers on SARS2/Covid-19. These have covered all kinds of different topics concerning the virus.

  •  
  •  
  • 9
  •  
  •  
  •  
  •  

1 Comment

Leave a Reply

Your email address will not be published.


*